Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel

被引:107
作者
Dinerman, AA
Cappello, J
Ghandehari, H
Hoag, SW
机构
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Prot Polymer Technol Inc, San Diego, CA 92121 USA
关键词
genetically engineered polymers; drug delivery; silk-elastinlike; hydrogels;
D O I
10.1016/S0142-9612(02)00164-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The influence of environmental conditions such as pH, temperature, and ionic strength on the equilibrium swelling ratio of physically crosslinked networks of a genetically engineered silk-elastinlike protein-based copolymer (SELP) with an amino acid repeat sequence of [(GVGVP)(4)GKGVP(GVGVP)(3)(GAGAGS)(4)](12) was investigated. The effects of gelation cure time and initial polymer concentration on the equilibrium swelling ratio and soluble fraction of the hydrogels were also studied. It was found that the soluble fraction linearly correlated with the initial polymer concentration at higher gelation times. Soluble fraction results suggest that final hydrogel water content may be controlled by both initial polymer concentration and gelation time. Equilibrium swelling studies demonstrated that these hydrogels are relatively insensitive to environmental changes such as pH, temperature, and ionic strength. Over the concentration range studied, it was found that an increase in gelation time at 37degreesC resulted in lower hydrogel weight equilibrium swelling ratios, which corresponds to less soluble polymer released post-gelation. Together, these results have implications for the controlled delivery of bioactive agents from silk-elastinlike hydrogels. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4203 / 4210
页数:8
相关论文
共 12 条
[1]   GENETIC-ENGINEERING OF STRUCTURAL PROTEIN POLYMERS [J].
CAPPELLO, J ;
CRISSMAN, J ;
DORMAN, M ;
MIKOLAJCZAK, M ;
TEXTOR, G ;
MARQUET, M ;
FERRARI, F .
BIOTECHNOLOGY PROGRESS, 1990, 6 (03) :198-202
[2]   In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs [J].
Cappello, J ;
Crissman, JW ;
Crissman, M ;
Ferrari, FA ;
Textor, G ;
Wallis, O ;
Whitledge, JR ;
Zhou, X ;
Burman, D ;
Aukerman, L ;
Stedronsky, ER .
JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) :105-117
[3]  
Cappello J., 1997, CONTROLLED DRUG DELI, P439
[4]   Swelling behavior of γ-irradiation cross-linked elastomeric polypentapeptide-based hydrogels [J].
Lee, J ;
Macosko, CW ;
Urry, DW .
MACROMOLECULES, 2001, 34 (12) :4114-4123
[5]   Elastomeric polypentapeptides cross-linked into matrixes and fibers [J].
Lee, J ;
Macosko, CW ;
Urry, DW .
BIOMACROMOLECULES, 2001, 2 (01) :170-179
[6]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[7]   Synthesis and characterization of elastin-mimetic protein gels derived from a well-defined polypeptide precursor [J].
McMillan, RA ;
Conticello, VP .
MACROMOLECULES, 2000, 33 (13) :4809-4821
[8]   Genetically engineered polymers for drug delivery [J].
Nagarsekar, A ;
Ghandehari, H .
JOURNAL OF DRUG TARGETING, 1999, 7 (01) :11-32
[9]  
NAGARSEKAR A, IN PRESS J BIOMED MA
[10]   Reversible hydrogels from self-assembling artificial proteins [J].
Petka, WA ;
Harden, JL ;
McGrath, KP ;
Wirtz, D ;
Tirrell, DA .
SCIENCE, 1998, 281 (5375) :389-392